跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,605 条关于
“Pyruvate Dehydrogenase Kinase”
全部
4,605
临床试验
2,038
药物
500
机构
194
资讯
1,873
去年
FDA Grants Priority Review to Saol Therapeutics' SL1009 for Rare Pediatric Mitochondrial Disorder
2个月前
Saol Therapeutics Resubmits NDA for SL1009 (DCA) in Pyruvate Dehydrogenase Complex Deficiency Following FDA Alignment
去年
Avanzanite Partners with Agios to Commercialize First-in-Class Pyruvate Kinase Activator Across Europe
2年前
FDA Approves Pyrukynd as First Treatment for Pyruvate Kinase Deficiency
2个月前
Nanoparticles Navigating the Blood–Brain Barrier: A New Frontier in Neurodegenerative Disease Therapy
5年前
Agios Submits New Drug Application to FDA for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency
4年前
FDA Approves Pyrukynd (mitapivat) for Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency
去年
Agios' Mitapivat Achieves Primary Endpoint in Phase 3 Trial for Children with PK Deficiency
去年
Agios' Mitapivat Receives Positive CHMP Opinion for Thalassemia Treatment in Europe
去年
Glycolytic Reprogramming Emerges as Key Therapeutic Target in Gastric Cancer
第 1 页，共 188 页
上一页
下一页
